Janux Therapeutics, Inc. (JANX)
15.70
+0.12
(+0.77%)
USD |
NASDAQ |
Dec 11, 09:37
Janux Therapeutics Research and Development Expense (TTM): 115.15M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Stoke Therapeutics, Inc. | 117.76M |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| Editas Medicine, Inc. | 105.31M |
| Syndax Pharmaceuticals, Inc. | 245.67M |
| Entrada Therapeutics, Inc. | 135.78M |